Symptoms of
lithium toxicity, not always associated with raised
lithium levels, have been described in 4 patients and 4 healthy subjects when they were also given
methyldopa.
Avoid concurrent use whenever possible, but if concurrent use is essential the effects should be closely monitored.
Serum lithium monitoring may be unreliable because
symptoms of
toxicity can occur even though the levels remain within the normally accepted therapeutic range.